title: Does early (treatment in) BENEFIT lead to late MS benefit?
authors: From the Partners Multiple Sclerosis Center (B.C.H.), Brigham and Women's Hospital, Boston; Biostatistics Center (B.C.H.), Massachusetts General Hospital, Boston; and Department of Neurology (B.G.W.), Mayo Clinic, Rochester, MN. bchealy@partners.org.
authors: Brian C
authors: BC
authors: Healy
authors: From the Partners Multiple Sclerosis Center (B.C.H.), Brigham and Women's Hospital, Boston; Biostatistics Center (B.C.H.), Massachusetts General Hospital, Boston; and Department of Neurology (B.G.W.), Mayo Clinic, Rochester, MN.
authors: Brian G
authors: BG
authors: Weinshenker
mesh_terms: D003711:Demyelinating Diseases / Q000188:drug therapy*; D018450:Disease Progression; D061345:Early Medical Intervention; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy; D017063:Outcome Assessment, Health Care